Myomo (MYO) Other Non-Current Assets (2016 - 2025)
Myomo (MYO) posted Other Non-Current Assets of $575000.0 for Q4 2025, up 241.55% on a QoQ basis from $168350.0 in Q3 2025, and up 53.33% year-over-year from $375000.0 in Q4 2024.
Myomo (MYO) Other Non-Current Assets (2016 - 2025) Analysis & Trends
Myomo's Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $575000.0 for Q4 2025.
- Quarterly Other Non-Current Assets rose 53.33% year-over-year to $575000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $575000.0 (up 53.33% YoY) and the FY2025 annual result came in at $575000.0, up 53.33% from the prior year.
- Other Non-Current Assets was $575000.0 for Q4 2025 at Myomo, up from $168350.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $575000.0 in Q4 2025 and bottomed at $4955.0 in Q1 2024.
- A 5-year average of $185569.9 and a median of $111034.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 95.54% — and 2025, when it surged 7468.11%.
- Myomo's Other Non-Current Assets stood at $95330.0 in 2021, then gained by 16.47% to $111034.0 in 2022, then retreated by 17.83% to $91237.0 in 2023, then surged by 311.02% to $375000.0 in 2024, then jumped by 53.33% to $575000.0 in 2025.
- Business Quant data shows MYO's Other Non-Current Assets at $575000.0 in Q4 2025, $168350.0 in Q3 2025, and $286670.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 575,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 575,000.00 |
| Sep 30, 2025 | 168,350.00 |
| Jun 30, 2025 | 286,670.00 |
| Mar 31, 2025 | 375,000.00 |
| Dec 31, 2024 | 375,000.00 |
| Sep 30, 2024 | 205,440.00 |
| Jun 30, 2024 | 219,891.00 |
| Mar 31, 2024 | 4,955.00 |
| Dec 31, 2023 | 91,237.00 |
| Sep 30, 2023 | 91,237.00 |
| Jun 30, 2023 | 111,034.00 |
| Mar 31, 2023 | 111,034.00 |
| Dec 31, 2022 | 111,034.00 |
| Sep 30, 2022 | 111,034.00 |
| Jun 30, 2022 | 111,034.00 |
| Mar 31, 2022 | 111,409.00 |
| Dec 31, 2021 | 95,330.00 |
| Sep 30, 2020 | 75,000.00 |
| Jun 30, 2020 | 75,000.00 |
| Mar 31, 2020 | 75,000.00 |